Prepare now to use convalescent plasma for the next pandemic Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to treat patients.

Prepare now to use convalescent plasma for the next pandemic. Whether it’s H5N1 avian flu or something else, convalescent plasma will play a role [Dec 26, 2024] @DrMJoyner @ScottWrightMD @ACasadevall1 @statnews
www.statnews.com/2024/12/26/h... #COVID19CP

COVID-19 Convalescent Plasma | Learn MoreMobile High Titer COVID-19 Convalescent Plasma is now available to order through OneBlood.

Licensed High Titer COVID-19 Convalescent Plasma (CCP): ORDER FORM. OneBlood Receives @US_FDA Approval
www.oneblood.org/pages/high-t... #COVID19CP #COVID19
Press Release (1/13/25): www.oneblood.org/media/press-... HT @ACasadevall1 cc @DrMJoyner @DrJPHenderson

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis [Jan 12, 2023] @jwsenefeld et al. @ACasadevall1 @DrMJoyner @JAMANetworkOpen jamanetwork.com/journals/jam... #COVID19CP #COVID19

Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients [Oct 26, 2023] Misset et al. @NEJM www.nejm.org/doi/full/10.... #NCT0455847 #COVID19CP #COVID19

Convalescent Plasma for Covid-19–Induced ARDS [Jan 25, 2024] @jwsenefeld @DrJPHenderson @DrMJoyner @NEJM Letter DOI: 10.1056/NEJMc2313675 #COVID19CP #COVID19

Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial {Pre-print} [Nov 9, 2024] Hoffmann et al. @TheLancet papers.ssrn.com/sol3/papers.... #NCT05271929 #COVID19CP #COVID19

US FDA Revokes Authorization for Four COVID Antibody Drugs The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from Eli Lilly and...

. @US_FDA Revokes Authorization for Four COVID Antibody Drugs [Decc 23, 2024] @Medscape @Reuters
www.medscape.com/s/viewarticl... #COVID19 #COVID19CP

Prepare now to use convalescent plasma for the next pandemic Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to treat patients.

Prepare now to use convalescent plasma for the next pandemic. Whether it’s H5N1 avian flu or something else, convalescent plasma will play a role [Dec 26, 2024] @DrMJoyner @ScottWrightMD @ACasadevall1 @statnews
www.statnews.com/2024/12/26/h... #COVID19CP

OneBlood becomes first in US to use High Titer plasma regularly to keep immunocompromised from getting COVID Five years after the COVID-19 pandemic began, millions who are considered immunocompromised still avoid crowds and even family events. But now, with a new FDA approval, things could change.

OneBlood becomes first in US to use High Titer plasma regularly to keep immunocompromised from getting COVID [Jan 13, 2025] by @lloydsowers
www.fox13news.com/news/onebloo... #COVID19CP #COVID19 HT @DrMJoyner

twitter.com/DrMJoyner/st... #COVID19CP #CCC19 #COVID19nCancer cc @DrJPHenderson @hemoncwarner.bsky.social @equis @pgrivasmdphd.bsky.social

COVID-19 Convalescent Plasma | Learn MoreMobile High Titer COVID-19 Convalescent Plasma is now available to order through OneBlood.

Licensed High Titer COVID-19 Convalescent Plasma (CCP): ORDER FORM. OneBlood Receives @US_FDA Approval
www.oneblood.org/pages/high-t... #COVID19CP #COVID19
Press Release (1/13/25): www.oneblood.org/media/press-... HT @ACasadevall1 cc @DrMJoyner @DrJPHenderson

Frontiers | Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases Immunosuppressant conditions such as hematological malignancies increase the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ...

Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Pts w/ Complete Remission B-Cell Lymphoma & Anti-CD20 mAb Therapy: A Case Report of 2 Cases [Apr 14, 2022] Martínez-Chinchilla et al. @FrontImmunol ow.ly/yOSa50IL3mn #COVID19nCancer #lymsm #IDonc #COVID19CP

Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data The urgent response to the COVID-19 pandemic has highlighted the importance of diverse, real-world data sources, such as electronic health records, insurance claims, and patient registries, to further...

Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc ow.ly/wTHl50FcSHZ #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role...

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

COVID-19 Convalescent Plasma | Learn MoreMobile High Titer COVID-19 Convalescent Plasma is now available to order through OneBlood.

Licensed High Titer COVID-19 Convalescent Plasma (CCP): ORDER FORM. OneBlood Receives @US_FDA Approval
www.oneblood.org/pages/high-t... #COVID19CP #COVID19
Press Release (1/13/25): www.oneblood.org/media/press-... HT @ACasadevall1 cc @DrMJoyner @DrJPHenderson

Prepare now to use convalescent plasma for the next pandemic Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to treat patients.

Prepare now to use convalescent plasma for the next pandemic. Whether it’s H5N1 avian flu or something else, convalescent plasma will play a role [Dec 26, 2024] @DrMJoyner @ScottWrightMD @ACasadevall1 @statnews
www.statnews.com/2024/12/26/h... #COVID19CP

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

Prepare now to use convalescent plasma for the next pandemic Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to treat patients.

Prepare now to use convalescent plasma for the next pandemic. Whether it’s H5N1 avian flu or something else, convalescent plasma will play a role [Dec 26, 2024] @DrMJoyner @ScottWrightMD @ACasadevall1 @statnews
www.statnews.com/2024/12/26/h... #COVID19CP

Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial Background: COVID-19 convalescent plasma (CCP) is a treatment option for COVID-19. This study investigated the safety and efficacy of early, very high-titre CCP

Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial {Pre-print} [Nov 9, 2024] Hoffmann et al. The Lancet papers.ssrn.com/sol3/papers.... #NCT05271929 #COVID19CP #COVID19

Survival in Patients With Hematologic Cancers and COVID-19 This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc